Novel insertion and deletion mutants of RpoB that render Mycobacterium smegmatis RNA polymerase resistant to rifampicin-mediated inhibition of transcription
The startling increase in the occurrence of rifampicin (Rif) resistance in the clinical isolates of Mycobacterium tuberculosis worldwide is posing a serious concern to tuberculosis management. The majority of Rif resistance in bacteria arises from mutations in the RpoB subunit of the RNA polymerase. We isolated M. smegmatis strains harbouring either an insertion (6 aa) or a deletion (10 aa) in their RpoB proteins. Although these strains showed a compromised fitness for growth in 7H9 Middlebrook medium, their resistance to Rif was remarkably high. The attenuated growth of the strains correlated with decreased specific activities of the RNA polymerases from the mutants. While the RNA polymerases from the parent or a mutant strain (harbouring a frequently occurring mutation, H442Y, in RpoB) were susceptible to Rif-mediated inhibition of transcription from calf thymus DNA, those from the insertion and deletion mutants were essentially refractory to such inhibition. Three-dimensional structure modelling revealed that the RpoB amino acids that interact with Rif are either deleted or unable to interact with Rif due to their unsuitable spatial positioning in these mutants. We discuss possible uses of the RpoB mutants in studying transcriptional regulation in mycobacteria and as potential targets for drug design.
BoshoffH. I.,
ReedM. B.,
BarryC. E.III,
MizrahiV.2003; DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis. Cell 113:183–193
GaribyanL.,
HuangT.,
KimM.,
WolffE.,
NguyenA.,
NguyenT.,
DiepA.,
HuK.,
IversonA.other authors2003; Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair (Amst 2:593–608
HerreraL.,
JimenezS.,
ValverdeA.,
Garcia-ArandaM. A.,
Saez-NietoJ. A.2003; Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996–2001). Description of new mutations in the rpoB gene and review of the literature. Int J Antimicrob Agents 21:403–408
HershbergR.,
LipatovM.,
SmallP. M.,
ShefferH.,
NiemannS.,
HomolkaS.,
RoachJ. C.,
KremerK.,
PetrovD. A.other authors2008; High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol 6:e311
HetheringtonS. V.,
WatsonA. S.,
PatrickC. C.1995; Sequence and analysis of the rpoB gene of Mycobacterium smegmatis. Antimicrob Agents Chemother 39:2164–2166
HinkleD. C.,
MangelW. F.,
ChamberlinM. J.1972; Studies of the binding of Escherichia coli RNA polymerase to DNA. IV. The effect of rifampicin on binding and on RNA chain initiation. J Mol Biol 70:209–220
HuY.,
ManganJ. A.,
DhillonJ.,
SoleK. M.,
MitchisonD. A.,
ButcherP. D.,
CoatesA. R.2000; Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide. J Bacteriol 182:6358–6365
JainR.,
KumarP.,
VarshneyU.2007; A distinct role of formamidopyrimidine DNA glycosylase (MutM) in down-regulation of accumulation of G, C mutations and protection against oxidative stress in mycobacteria. DNA Repair (Amst 6:1774–1785
JinD. J.,
GrossC. A.1988; Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J Mol Biol 202:45–58
JinD. J.,
CashelM.,
FriedmanD. I.,
NakamuraY.,
WalterW. A.,
GrossC. A.1988; Effects of rifampicin resistant rpoB mutations on antitermination and interaction with nusA in Escherichia coli. J Mol Biol 204:247–261
LevinM. E.,
HatfullG. F.1993; Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance. Mol Microbiol 8:277–285
MalshettyV. S.,
JainR.,
SrinathT.,
KurthkotiK.,
VarshneyU.2010; Synergistic effects of UdgB and Ung in mutation prevention and protection against commonly encountered DNA damaging agents in Mycobacterium smegmatis. Microbiology 156:940–949
OhnoH.,
KogaH.,
KohnoS.,
TashiroT.,
HaraK.1996; Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob Agents Chemother 40:1053–1056
SrinivasanN.,
BlundellT. L.1993; An evaluation of the performance of an automated procedure for comparative modelling of protein tertiary structure. Protein Eng 6:501–512
StoverC. K.,
de la CruzV. F.,
FuerstT. R.,
BurleinJ. E.,
BensonL. A.,
BennettL. T.,
BansalG. P.,
YoungJ. F.,
LeeM. H.other authors1991; New use of BCG for recombinant vaccines. Nature 351:456–460
SutcliffeM. J.,
HayesF. R.,
BlundellT. L.1987; Knowledge based modelling of homologous proteins, Part II: Rules for the conformations of substituted sidechains. Protein Eng 1:385–392
TaniguchiH.,
AramakiH.,
NikaidoY.,
MizuguchiY.,
NakamuraM.,
KogaT.,
YoshidaS.1996; Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol Lett 144:103–108
UnniramanS.,
ChatterjiM.,
NagarajaV.2002; DNA gyrase genes in Mycobacterium tuberculosis: a single operon driven by multiple promoters. J Bacteriol 184:5449–5456
VasanthakrishnaM.,
KumarN. V.,
VarshneyU.1997; Characterization of the initiator tRNA gene locus and identification of a strong promoter from Mycobacterium tuberculosis. Microbiology 143:3591–3598
VenkateshJ.,
KumarP.,
KrishnaP. S.,
ManjunathR.,
VarshneyU.2003; Importance of uracil DNA glycosylase in Pseudomonas aeruginosa and Mycobacterium smegmatis, G+C-rich bacteria, in mutation prevention, tolerance to acidified nitrite, and endurance in mouse macrophages. J Biol Chem 278:24350–24358
WegrzynA.,
Szalewska-PalaszA.,
BlaszczakA.,
LiberekK.,
WegrzynG.1998; Differential inhibition of transcription from σ70- and σ32-dependent promoters by rifampicin. FEBS Lett 440:172–174
WeinerS. J.,
KollmanP. A.,
CaseD. A.,
SinghU. C.,
GhioC.,
AlagonaG.,
ProfetaS.,
WeinerP.1984; A new force field for molecular mechanical simulation of nucleic acids and proteins. J Am Chem Soc 106:765–784
YanofskyC.,
HornV.1981; Rifampin resistance mutations that alter the efficiency of transcription termination at the tryptophan operon attenuator. J Bacteriol 145:1334–1341
Novel insertion and deletion mutants of RpoB that render Mycobacterium smegmatis RNA polymerase resistant to rifampicin-mediated inhibition of transcription